Journal of Clinical Epidemiology
Volume 59, Issue 5 , Pages 472-477 , May 2006

Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes

  • Sheri L. Maddigan

      Affiliations

    • Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
    • Institute of Health Economics, #1200 – 10405 Jasper Avenue, Edmonton, Alberta T5J 3N4, Canada
    • ,
  • David H. Feeny

      Affiliations

    • Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
    • Institute of Health Economics, #1200 – 10405 Jasper Avenue, Edmonton, Alberta T5J 3N4, Canada
    • Department of Economics, University of Alberta, Edmonton, Alberta, Canada
    • Health Utilities Inc., Dundas, Ontario, Canada
    • Kaiser Center for Health Research, Portland, OR, USA
    • ,
  • Sumit R. Majumdar

      Affiliations

    • Institute of Health Economics, #1200 – 10405 Jasper Avenue, Edmonton, Alberta T5J 3N4, Canada
    • Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Karen B. Farris

      Affiliations

    • College of Pharmacy, The University of Iowa, Iowa City, IA, USA
    • ,
  • Jeffrey A. Johnson

      Affiliations

    • Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
    • Institute of Health Economics, #1200 – 10405 Jasper Avenue, Edmonton, Alberta T5J 3N4, Canada
    • Corresponding Author InformationCorresponding author. Tel.: 780-448-4881; fax: 780-448-0018.

,Accepted 25 September 2005.

References 

  1. Shen W, Kotsanos JG, Huster WJ, Mathias SD, Andrejasich CM, Patrick DL. Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care. 1999;37(4:Suppl Lilly):AS45–AS66
  2. DCCT Research Group . Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care. 1988;11:725–732
  3. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–629
  4. de Visser CL, Bilo HJ, Groenier KH, de Visser W, Jong Meyboom-de B. The influence of cardiovascular disease on quality of life in type 2 diabetics. Qual Life Res. 2002;11:249–261
  5. Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care. 1997;20:299–305
  6. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 1994;17:267–274
  7. Maddigan SL, Majumdar SR, Toth EL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes. Health Qual Life Outcomes. 2003;1:78
  8. Maddigan SL, Feeny DH, Johnson JA, DOVE Investigators . A comparison of the Health Utilities Indices mark 2 and mark 3 in type 2 diabetes. Med Decis Making. 2003;23:489–501
  9. Maddigan SL, Feeny DH, Johnson JA. Construct validity of the RAND-12 and Health Utilities Index mark 2 and mark 3 in type 2 diabetes. Qual Life Res. 2004;13:435–448
  10. Grootendorst P, Feeny D, Furlong W. Health Utilities Index mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care. 2000;38:290–299
  11. Feeny D, Farris K, Cote I, Johnson JA, Tsuyuki RT, Eng K. A cohort study found the RAND-12 and Health Utilities Index mark 3 demonstrated construct validity in high-risk primary care patients. J Clin Epidemiol. 2005;58:138–141
  12. Beland Y. Canadian community health survey: methodological overview. Health Rep. 2002;13:9–14
  13. Maddigan SL, Feeny DH, Majumdar SR, Farris KB, Johnson JA. Construct validity of the Health Utilities Index mark 3 in type 2 diabetes: evidence from a nationally representative sample of Canadians. Institute of Health Economics Working Paper 05-02. Edmonton: Institute of Health Economics. 2005;
  14. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index mark 3 system. Med Care. 2002;40:113–128
  15. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54
  16. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458–463
  17. Koopmanschap M. Advisory Board. Coping with type II diabetes: the patient's perspective. Diabetologia. 2002;45:S18–S22
  18. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15:205–218
  19. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25:2238–2243
  20. Maddigan SL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res. 2005;14:1311–1320
  21. Statistics Canada. Canadian Community Health Survey (CCHS): cycle 1.1. Public use microdata file documentation. Ottawa: Statistics Canada; 2004;
  22. Patten SB, Brandon-Christie J, Devji J, Sedmak B. Performance of the composite international diagnostic interview short form for major depression in a community sample. Chronic Dis Can. 2000;21:68–72
  23. Furlong W, Feeny D, Torrance GW, Goldsmith C, DePauw S, Boyle M, Denton M, Zhu Z. Multiplicative Multi-Attribute Utility Function for the Health Utilities Index Mark 3 (HUI3) System: A Technical Report. McMaster University, Centre for Health Economics and Policy Analysis Working Paper No. 98-11 Accessed February 6, 2006. Available at: http://www.healthutilies.com.
  24. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–1078
  25. Centre for Chronic Disease Prevention and Control. Diabetes in Canada. 2nd ed.. Ottawa: Health Canada; 2002;

PII: S0895-4356(05)00344-6

doi: 10.1016/j.jclinepi.2005.09.010

Journal of Clinical Epidemiology
Volume 59, Issue 5 , Pages 472-477 , May 2006

Article Tools